Philadelphia Launches Campaign to Address Stimulant Use and Heart Health

The Philadelphia Department of Public Health has launched a new campaign aimed at educating residents about the relationship between stimulant use and heart health. The initiative, led by the Division of Substance Use Prevention and Harm Reduction (SUPHR), equips Philadelphians with the tools necessary to engage in meaningful discussions with healthcare providers regarding the effects of stimulants on cardiovascular wellness.

This campaign seeks to disseminate critical information on heart health and identify additional risk factors associated with stimulant use. It connects individuals to accessible primary care resources and clinics throughout the city, ensuring that those affected can receive the support they need.

Dr. Daniel Teixeira da Silva, the director of SUPHR, explained that the groundwork for this project has been in development for several years. The initiative includes providing clinicians with effective conversation starters for discussing heart health with their patients. It also offers patients guiding points to help facilitate these discussions. Dr. da Silva emphasized the importance of empowering patients to initiate conversations about their heart health and drug use with their healthcare providers.

The campaign’s website features a variety of resources, including conversation starters designed to help patients engage with their primary care physicians. For individuals without a primary care provider, the site lists clinics with walk-in hours, particularly in areas most impacted by stimulant overdoses.

This marks the first time that the Philadelphia health department has offered guidance on the potential damage stimulants can inflict on heart health, as well as how these substances can lead to fatal overdose situations.

Stimulant Use and Its Impact on Communities

Data from the health department reveals a concerning trend: while overdose deaths among white individuals decreased by 19% from 2019 to 2023, fatalities among the city’s Black population surged by 61% in the same period. Alarmingly, 80% of these reported deaths involved stimulant use.

Recent statistics indicate that while overall overdose deaths began to decline in 2023 compared to the previous year, the decrease was more pronounced among white residents, who experienced a 15% reduction, compared to a 6% decrease among Black residents. The regions of North, West, and Southwest Philadelphia have reported the highest incidents of stimulant-related overdoses. In 2023, the average age of Black men who succumbed to a stimulant overdose was 52 years, which is notably older than the average age of individuals who died from opioid overdoses.

Understanding Stimulants and Their Effects

Stimulants, commonly referred to as “uppers,” are drugs that accelerate the functioning of the body’s central nervous system. They encompass a wide range of substances, from everyday items like coffee to prescribed medications such as Adderall, as well as illegal drugs like cocaine and crystal methamphetamine.

Frequent consumption of stimulants can adversely affect heart rate and blood pressure, potentially leading to addiction and serious heart conditions. The health department’s website offers additional resources to educate the public about these risks.

This initiative underscores a critical need for health education concerning stimulant use and its implications for heart health. By facilitating open dialogue between patients and healthcare providers, the Philadelphia Department of Public Health aims to foster a healthier community equipped to tackle the challenges posed by substance use.